SEC Form 4 · accession 0001493152-18-003630
PetLife Pharmaceuticals, Inc. · PTLF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vyvyan Campbell
Director
Period of report
Feb 28, 2018
Accepted (ET)
Mar 20, 2018 · 1:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001354591
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2018 | P | 305,000 | $4,017.00 | A | 1,305,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Purchased stock.